Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2012-05-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
NCT02493478
Apneic Oxygenation in the Pediatric Intensive Care Unit
NCT03374046
Effectiveness of the Routine Use of Extubation Protocol on the Incidence of Occurrence of Failures Number of Extubation in Pediatric Resuscitation
NCT03129815
Evaluation of Extubation Criteria in Children With Upper Respiratory Infection (URI)
NCT04155892
Incidence and Risk Factors of Extubation Failure in Pediatric Resuscitation
NCT03129802
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypothesis- Successful extubation in a pediatric intensive care unit is dependent on variables, which can be identified and the chances of success predicted. A clinical practice based upon such a prediction model, will improve the quality of care provided to the patients.
Type- Prospective chart review .
Procedure- Over 1 year period, all planned extubations in the intensive care unit to be recorded on a designated form and standard variables charted. All extubation decisions are to be made by the covering attending physician and at no time, the study protocol will affect/influence or alter the standard patient care. All data will be collected retrospectively after the extubation event. All included patients will be assigned a unique identification number (UID) by the investigator, who will secure the patient identifiers in an encrypted electronic file. Extubation failure will be defined as reintubation within 72 hours of a planned extubation and will be further classified as early (\<12 hours) and late (12-72 hours) extubation failure. The cause of extubation failure will be recorded (as identified by the attending physician on service, who is not involved in the study).
Data collection and statistical analysis- The data will be collected on a standard form. The data collected will be periodically logged in an electronic data base and analyzed. Investigators will perform an interim analysis at the end of 6 months and a final analysis of the data at the end of 1 year period. Since this is an observational study, all the extubations in the time period, will be included. Based on 2010 data collected, for monitoring unplanned extubations (300 extubations) and considering recent expansion in their unit, investigators expect about 500 extubations in the time period.
For statistical analysis, group that fail extubation, will be compared, with the group that was an extubation success. Standard demographics (age, sex), patient disease related factors (diagnosis, duration of intubation, secretions, sedation level), care factors (CPAP trials, cuff leak test, use of pre-extubation decadron, p/f ratio prior to extubation), and post extubation care (post extubation respiratory support, stridor, blood gas) along with any complication during extubation and reintubation and reasons for reintubation will be collected and compared. As two groups are being compared, bivariate analyses utilizing Chi-square tests or univariate logistic regression for categorical variables and Student t -tests for interval variables, will be done. Based on 9.9% extubation failure rate in 2010, investigators expect \~50 extubation failures in the time frame. From the preliminary data, investigators also expect a 40% difference in the primary variables of comparison (age, secretions, sedation level). For statistical analysis at 95% confidence interval and 80% power, investigators will be able to detect differences between groups in proportions of approximately 20% with the expected sample size or differences of 25% with a 99% CI. The investigators also will conduct multivariate logistic regression analysis using extubation failure as the dependent variable and calculate the independent odds ratio for significant predictor variables. Early Vs late extubation failures, will also be compared. From literature, investigators assume 80% of extubation failures to be early (from their estimate, 40 early extubation failures and 10 late extubation failures, in 1 year period). They do not expect statistically significant results from the numbers in present trial period, however they expect to get trends to plan a further study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Extubation Success
Patients who do not require re-intubation, upto 72 hours after a planned extubation in the pediatric intensive care unit.
No interventions assigned to this group
Extubation failure
Patients who required re-intubation within 72 hours after a planned extubation in pediatric intensive care unit. To be further classified as early \<12 hour and late 12-72 hour, extubation failures.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Montefiore Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sandeep Tripathi, M.D
Role: PRINCIPAL_INVESTIGATOR
Montefiore Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montefiore Medical center
The Bronx, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-02-051E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.